The response of atmospheric CO2 and climate to the reconstructed variability in solar irradiance and radiative forcing by volcanoes over the last millennium is examined by applying a coupled physical-biogeochemical climate model that includes the Lund-Potsdam-Jena dynamic global vegetation model (LPJ-DGVM) and a simplified analogue of a coupled atmosphere-ocean general circulation model. The mo...

BACKGROUND/AIMS Nonsteroidal anti-inflammatory drugs relieve osteoarthritis (OA) symptoms but cause adverse effects. D-002, a mixture of beeswax alcohols, is effective against experimental OA. A pilot study found that D-002 (50 mg/day) for 8 weeks improves OA symptoms. The aim of this study was to investigate the effects of D-002 (50 to 100 mg/day) administered for 6 weeks on OA symptoms. MET...

Here we studied ability of two naphthoquinones to inhibit Leishmania growth (2,3-dichloro-5,8-dihydroxy-1,4-naphthoquinone (TR 001) and 2,3-dibromo-1,4-naphthoquinone (TR 002). TR 001 was more efficient than TR 002 in inducing killing of promastigotes and intracellular amastigotes. These values compare well to those obtained with the standard first-line antileishmanial agent sodium stiboglucona...

Algorithm to Find All Cliques in a Graph A. Ashok Kumar Department of Computer Science , St. Xavier’s College (Autonomous), Palayamkottai 627 002. E-mail: [email protected] S. Athisayanathan Research Department of Mathematics, St. Xavier’s College (Autonomous),Palayamkottai 627 002. E-mail: [email protected] A. Antonysamy Research Department of Mathematics, St. Xavier’s College...

NOV-002 is a novel glutathione disulfide mimetic that when administered in combination with standard chemotherapeutic regimens has resulted in increased efficacy (survival, tumor response) and improved tolerance to chemotherapy (e.g., hematologic recovery) in advanced non-small cell lung cancer patients. We show that NOV-002, which is not cytotoxic as a single agent, generated time- and concent...

NOV-002 is a novel glutathione disulfide mimetic that when administered in combination with standard chemotherapeutic regimens has resulted in increased efficacy (survival, tumor response) and improved tolerance to chemotherapy (e.g., hematologic recovery) in advanced non–small cell lung cancer patients. We show that NOV-002, which is not cytotoxic as a single agent, generated timeand concentra...